Literature DB >> 17332281

Epigenetic silencing of the candidate tumor suppressor gene Per1 in non-small cell lung cancer.

Sigal Gery1, Naoki Komatsu, Norihiko Kawamata, Carl W Miller, Julian Desmond, Renu K Virk, Alberto Marchevsky, Robert Mckenna, Hirokuni Taguchi, H Phillip Koeffler.   

Abstract

PURPOSE: Epigenetic events are a critical factor contributing to cancer development. The purpose of this study was to identify tumor suppressor genes silenced by DNA methylation and histone deacetylation in non-small cell lung cancer (NSCLC). EXPERIMENTAL
DESIGN: We used microarray analysis to screen for tumor suppressor genes.
RESULTS: We identified Per1, a core circadian gene, as a candidate tumor suppressor in lung cancer. Although Per1 levels were high in normal lung, its expression was low in a large panel of NSCLC patient samples and cell lines. Forced expression of Per1 in NSCLC cell lines led to significant growth reduction and loss of clonogenic survival. Recent studies showed that epigenetic regulation, particularly histone H3 acetylation, is essential for circadian function. Using bisulfite sequencing and chromatin immunoprecipitation, we found that DNA hypermethylation and histone H3 acetylation are potential mechanisms for silencing Per1 expression NSCLC.
CONCLUSIONS: These results support the hypothesis that disruption of circadian rhythms plays an important role in lung tumorigenesis. Moreover, our findings suggest a novel link between circadian epigenetic regulation and cancer development.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17332281     DOI: 10.1158/1078-0432.CCR-06-1730

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  57 in total

1.  Transcription factor CCAAT/enhancer-binding protein alpha and critical circadian clock downstream target gene PER2 are highly deregulated in diffuse large B-cell lymphoma.

Authors:  Nils H Thoennissen; Gabriela B Thoennissen; Sam Abbassi; Shayan Nabavi-Nouis; Tim Sauer; Ngan B Doan; Sigal Gery; Carsten Müller-Tidow; Jonathan W Said; H Phillip Koeffler
Journal:  Leuk Lymphoma       Date:  2012-02-21

2.  Circadian-independent cell mitosis in immortalized fibroblasts.

Authors:  Mijung Yeom; Julie S Pendergast; Yoshihiro Ohmiya; Shin Yamazaki
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-10       Impact factor: 11.205

Review 3.  Circadian rhythms and cancer.

Authors:  Sigal Gery; H Philip Koeffler
Journal:  Cell Cycle       Date:  2010-03-15       Impact factor: 4.534

Review 4.  The circadian control of skin and cutaneous photodamage.

Authors:  Joshua A Desotelle; Melissa J Wilking; Nihal Ahmad
Journal:  Photochem Photobiol       Date:  2012-02-21       Impact factor: 3.421

5.  A role for the clock gene per1 in prostate cancer.

Authors:  Qi Cao; Sigal Gery; Azadeh Dashti; Dong Yin; Yan Zhou; Jiang Gu; H Phillip Koeffler
Journal:  Cancer Res       Date:  2009-09-14       Impact factor: 12.701

6.  Altered expression patterns of clock gene mRNAs and clock proteins in human skin tumors.

Authors:  Zsuzsanna Lengyel; Csenge Lovig; Siri Kommedal; Rita Keszthelyi; György Szekeres; Zita Battyáni; Valér Csernus; András Dávid Nagy
Journal:  Tumour Biol       Date:  2012-12-15

7.  Circadian gene expression predicts patient response to neoadjuvant chemoradiation therapy for rectal cancer.

Authors:  Haijie Lu; Qiqi Chu; Guojiang Xie; Hao Han; Zheng Chen; Benhua Xu; Zhicao Yue
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

8.  Genome-wide profile of pleural mesothelioma versus parietal and visceral pleura: the emerging gene portrait of the mesothelioma phenotype.

Authors:  Oluf Dimitri Røe; Endre Anderssen; Eli Helge; Caroline Hild Pettersen; Karina Standahl Olsen; Helmut Sandeck; Rune Haaverstad; Steinar Lundgren; Erik Larsson
Journal:  PLoS One       Date:  2009-08-07       Impact factor: 3.240

9.  Circadian rhythm and its role in malignancy.

Authors:  Sobia Rana; Saqib Mahmood
Journal:  J Circadian Rhythms       Date:  2010-03-31

10.  Disrupting circadian homeostasis of sympathetic signaling promotes tumor development in mice.

Authors:  Susie Lee; Lawrence A Donehower; Alan J Herron; David D Moore; Loning Fu
Journal:  PLoS One       Date:  2010-06-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.